Cargando…

ABR, a novel inducer of transcription factor C/EBPα, contributes to myeloid differentiation and is a favorable prognostic factor in acute myeloid leukemia

Active BCR related (ABR) gene deactivates ras-related C3 botulinum toxin substrate 1 (RAC1), which plays an essential role in regulating normal hematopoiesis and in leukemia. BCR gene, closely related to ABR, acts as a tumor suppressor in chronic myeloid leukemia and has overlapping functions with A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Namasu, Carolina Yaeko, Katzerke, Christiane, Bräuer-Hartmann, Daniela, Wurm, Alexander Arthur, Gerloff, Dennis, Hartmann, Jens-Uwe, Schwind, Sebastian, Müller-Tidow, Carsten, Hilger, Nadja, Fricke, Stephan, Christopeit, Maximilian, Niederwieser, Dietger, Behre, Gerhard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732755/ https://www.ncbi.nlm.nih.gov/pubmed/29262589 http://dx.doi.org/10.18632/oncotarget.22093

Ejemplares similares

MicroRNA-143 targets ERK5 in granulopoiesis and predicts outcome of patients with acute myeloid leukemia
por: Hartmann, Jens-Uwe, et al.
Publicado: (2018)

miR-451a abrogates treatment resistance in FLT3-ITD-positive acute myeloid leukemia
por: Krakowsky, Rosanna H. E., et al.
Publicado: (2018)

Disruption of the C/EBPα—miR-182 balance impairs granulocytic differentiation
por: Wurm, Alexander Arthur, et al.
Publicado: (2017)

Nutritional Status at Diagnosis and Pre-transplant Weight Loss Impact Outcomes of Acute Myeloid Leukemia Patients Following Allogeneic Stem Cell Transplantation
por: Brauer, Dominic, et al.
Publicado: (2021)

The diagnostic red blood cell distribution width as a prognostic factor in acute myeloid leukemia
por: Vucinic, Vladan, et al.
Publicado: (2021)

High expression of the stem cell marker GPR56 at diagnosis identifies acute myeloid leukemia patients at higher relapse risk after allogeneic stem cell transplantation with the CD34(+)/CD38(-) population
por: Jentzsch, Madlen, et al.
Publicado: (2020)

High BAALC copy numbers in peripheral blood prior to allogeneic transplantation predict early relapse in acute myeloid leukemia patients
por: Jentzsch, Madlen, et al.
Publicado: (2017)

Outcomes of Older Patients with NPM1 Mutated and FLT3-ITD Negative Acute Myeloid Leukemia Receiving Allogeneic Transplantation
por: Jentzsch, Madlen, et al.
Publicado: (2020)

Prognostic Impact of Blood MN1 Copy Numbers Before Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia
por: Jentzsch, Madlen, et al.
Publicado: (2019)

A high hematopoietic cell transplantation comorbidity Index (HCT-CI) does not impair outcomes after non-myeloablative allogeneic stem cell transplantation in acute myeloid leukemia patients 60 years or older
por: Backhaus, Donata, et al.
Publicado: (2022)

Incubation of Immune Cell Grafts With MAX.16H5 IgG1 Anti-Human CD4 Antibody Prolonged Survival After Hematopoietic Stem Cell Transplantation in a Mouse Model for Fms Like Tyrosine Kinase 3 Positive Acute Myeloid Leukemia
por: Hilger, Nadja, et al.
Publicado: (2018)

C/EBPβ is a MYB- and p300-cooperating pro-leukemogenic factor and promising drug target in acute myeloid leukemia
por: Yusenko, Maria V., et al.
Publicado: (2021)

Myeloid transformation by MLL-ENL depends strictly on C/EBP
por: Wesolowski, Radoslaw, et al.
Publicado: (2020)

Allogeneic stem cell transplantation mitigates the adverse prognostic impact of high diagnostic BAALC and MN1 expression in AML
por: Jentzsch, Madlen, et al.
Publicado: (2020)

ELN risk stratification and outcomes in secondary and therapy-related AML patients consolidated with allogeneic stem cell transplantation
por: Jentzsch, Madlen, et al.
Publicado: (2020)

Prognostic relevance of remission and measurable residual disease status in AML patients prior to reduced intensity or non-myeloablative allogeneic stem cell transplantation
por: Jentzsch, Madlen, et al.
Publicado: (2021)

Abre la ventana /
por: Quintanilla Madero, Carmen
Publicado: (2003)

Impact of MRD status in patients with AML undergoing allogeneic stem cell transplantation in the first vs the second remission
por: Jentzsch, Madlen, et al.
Publicado: (2022)

The deregulated expression of miR-125b in acute myeloid leukemia is dependent on the transcription factor C/EBPα
por: Vargas Romero, P, et al.
Publicado: (2015)

In Vivo Deficiency of Both C/EBPβ and C/EBPε Results in Highly Defective Myeloid Differentiation and Lack of Cytokine Response
por: Akagi, Tadayuki, et al.
Publicado: (2010)

Styryl Quinazolinones as Potential Inducers of Myeloid Differentiation via Upregulation of C/EBPα
por: Sridhar, Radhakrishnan, et al.
Publicado: (2018)

CEBPG promotes acute myeloid leukemia progression by enhancing EIF4EBP1
por: Jiang, You, et al.
Publicado: (2021)

The Chinese HCT survey: a non-manipulated haploidentical transplantation procedure makes a novel contribution to data sharing within the regional and global transplant registries and to worldwide knowledge
por: Niederwieser, Dietger
Publicado: (2021)

The two kinases, AbrC1 and AbrC2, of the atypical two-component system AbrC are needed to regulate antibiotic production and differentiation in Streptomyces coelicolor
por: Rodríguez, Héctor, et al.
Publicado: (2015)

Expression of a specific extracellular matrix signature is a favorable prognostic factor in acute myeloid leukemia
por: Izzi, Valerio, et al.
Publicado: (2017)

Genome-wide association study identifies an acute myeloid leukemia susceptibility locus near BICRA
por: Walker, Christopher J., et al.
Publicado: (2018)

Measurable residual disease of canonical versus non-canonical DNMT3A, TET2, or ASXL1 mutations in AML at stem cell transplantation
por: Jentzsch, Madlen, et al.
Publicado: (2021)

De persiana que se abre /
por: Bernal Granados, Gabriel, 1973-
Publicado: (2000)

Pretreatment long interspersed element (LINE)-1 methylation levels, not early hypomethylation under treatment, predict hematological response to azacitidine in elderly patients with acute myeloid leukemia
por: Cross, Michael, et al.
Publicado: (2013)

Characterization of the Murine Myeloid Precursor Cell Line MuMac-E8
por: Fricke, Stephan, et al.
Publicado: (2014)

Case Report: Allogeneic Stem Cell Transplantation Following Induction With CPX-351 in Patients With Acute Myeloid Leukemia Is Feasible
por: Vucinic, Vladan, et al.
Publicado: (2020)

Block of C/EBPα function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations
por: Radomska, Hanna S., et al.
Publicado: (2006)

Lymphoid to Myeloid Cell Trans-Differentiation Is Determined by C/EBPβ Structure and Post-Translational Modifications
por: Stoilova, Bilyana, et al.
Publicado: (2013)

Myeloid C/EBPβ deficiency reshapes microglial gene expression and is protective in experimental autoimmune encephalomyelitis
por: Pulido-Salgado, Marta, et al.
Publicado: (2017)

Highly Elevated Serum Hepcidin in Patients with Acute Myeloid Leukemia prior to and after Allogeneic Hematopoietic Cell Transplantation: Does This Protect from Excessive Parenchymal Iron Loading?
por: Eisfeld, Ann-Kathrin, et al.
Publicado: (2011)

Low expression of ACLY associates with favorable prognosis in acute myeloid leukemia
por: Wang, Jinghan, et al.
Publicado: (2019)

Interaction between membranous EBP50 and myosin 9 as a favorable prognostic factor in ovarian clear cell carcinoma
por: Nakagawa, Mayu, et al.
Publicado: (2023)

El cielo no se abre : semblanza documental de Alfonso Reyes
por: Curiel, Fernando, 1942-
Publicado: (1995)

Clinical Implications of the FLT3-ITD Allelic Ratio in Acute Myeloid Leukemia in the Context of an Allogeneic Stem Cell Transplantation
por: Jentzsch, Madlen, et al.
Publicado: (2023)

Biosimilar agents in oncology/haematology: from approval to practice
por: Niederwieser, Dietger, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_mv3a8lg1g08ot1aogjo8d6cp7r